Working document QAS/11.

453
(Previous reference: WHO/PSM/QSM/2006.2)
Original: English

INDEX OF PHARMACOPOEIAS

The Index of Pharmacopoeias has been circulated to national pharmacopoeia commissions for their feedback and the data
received from them have been used to update the previous list. Links to online pharmacopoeias were provided where available.
Where no specific links to online pharmacopoeias are available, links to organizations of national pharmacopoeia commissions
are always listed.

The list is provided for reference purposes only and does not pretend to be complete.

In order to bring this list up to date we would appreciate any additional data you may have. Please address your observations to
Dr Sabine Kopp, Quality Assurance & Safety: Medicines, Medicines Policy and Standards, World Health Organization, 1211
Geneva 27, Switzerland; fax: (0041 22) 791 47 30 or e-mail: kopps@who.int.

_______________________________________________________________________________________________________________________
Index of pharmacopoeias
© World Health Organization 2011
All rights reserved.
Working document QAS/11.453
page 2

Table of Contents
I. NATIONAL....................................................................................................................................................................................................................6
1. ......................................................................................................................................................................................................................
Argentina.................................................................................................................................................................................................................................. 6
2. ......................................................................................................................................................................................................................
Austria....................................................................................................................................................................................................................................... 7
3. ......................................................................................................................................................................................................................
Belarus ..................................................................................................................................................................................................................................... 7
4. ......................................................................................................................................................................................................................
Belgium..................................................................................................................................................................................................................................... 7
5. ......................................................................................................................................................................................................................
Brazil ......................................................................................................................................................................................................................................... 8
6. ......................................................................................................................................................................................................................
China ........................................................................................................................................................................................................................................ 8
7. ......................................................................................................................................................................................................................
Croatia ...................................................................................................................................................................................................................................... 9
8. ......................................................................................................................................................................................................................
Czech Republic ....................................................................................................................................................................................................................... 9
9. ......................................................................................................................................................................................................................
Denmark................................................................................................................................................................................................................................. 10
10. ....................................................................................................................................................................................................................
Egypt....................................................................................................................................................................................................................................... 10
11. ....................................................................................................................................................................................................................
Finland.................................................................................................................................................................................................................................... 11
12. ....................................................................................................................................................................................................................
France..................................................................................................................................................................................................................................... 11
 Working document QAS/11.453
page 3
13. ....................................................................................................................................................................................................................
Germany................................................................................................................................................................................................................................. 11
14. ....................................................................................................................................................................................................................
Greece.................................................................................................................................................................................................................................... 12
15. ....................................................................................................................................................................................................................
Hungary.................................................................................................................................................................................................................................. 13
16. ....................................................................................................................................................................................................................
Iceland .................................................................................................................................................................................................................................... 13
17. ....................................................................................................................................................................................................................
India ........................................................................................................................................................................................................................................ 14
18. ....................................................................................................................................................................................................................
Indonesia................................................................................................................................................................................................................................ 14
19. ....................................................................................................................................................................................................................
Iran .......................................................................................................................................................................................................................................... 15
20. ....................................................................................................................................................................................................................
Ireland..................................................................................................................................................................................................................................... 15
21. ....................................................................................................................................................................................................................
Italy.......................................................................................................................................................................................................................................... 15
22. ....................................................................................................................................................................................................................
Japan ...................................................................................................................................................................................................................................... 16
23. ....................................................................................................................................................................................................................
Korea ...................................................................................................................................................................................................................................... 17
24. ....................................................................................................................................................................................................................
Lithuania................................................................................................................................................................................................................................. 17
25. ....................................................................................................................................................................................................................
Mexico .................................................................................................................................................................................................................................... 18
26. ....................................................................................................................................................................................................................
Montenegro............................................................................................................................................................................................................................ 19
27. ....................................................................................................................................................................................................................

3
Working document QAS/11.453
page 4
Norway ................................................................................................................................................................................................................................... 19
28. ....................................................................................................................................................................................................................
Pakistan.................................................................................................................................................................................................................................. 19
29. ....................................................................................................................................................................................................................
Philippines.............................................................................................................................................................................................................................. 20
30. ....................................................................................................................................................................................................................
Poland..................................................................................................................................................................................................................................... 20
31. ....................................................................................................................................................................................................................
Portugal .................................................................................................................................................................................................................................. 21
32. ....................................................................................................................................................................................................................
Republic of Serbia ................................................................................................................................................................................................................ 22
33. ....................................................................................................................................................................................................................
Romania................................................................................................................................................................................................................................. 22
34. ....................................................................................................................................................................................................................
Russian Federation .............................................................................................................................................................................................................. 22
35. ....................................................................................................................................................................................................................
Slovak Republic .................................................................................................................................................................................................................... 23
36. ....................................................................................................................................................................................................................
Slovenia.................................................................................................................................................................................................................................. 23
37. ....................................................................................................................................................................................................................
Spain....................................................................................................................................................................................................................................... 24
38. ....................................................................................................................................................................................................................
Sweden................................................................................................................................................................................................................................... 24
39. ....................................................................................................................................................................................................................
Switzerland ............................................................................................................................................................................................................................ 25
40. ....................................................................................................................................................................................................................
Thailand.................................................................................................................................................................................................................................. 25
41. ....................................................................................................................................................................................................................
Turkey..................................................................................................................................................................................................................................... 26
 Working document QAS/11.453
page 5
42. ....................................................................................................................................................................................................................
Ukraine ................................................................................................................................................................................................................................... 26
43. ....................................................................................................................................................................................................................
United Kingdom..................................................................................................................................................................................................................... 27
44. ....................................................................................................................................................................................................................
United States of America..................................................................................................................................................................................................... 27
45. ....................................................................................................................................................................................................................
Viet Nam.................................................................................................................................................................................................................................. 28

II. REGIONAL AND SUBREGIONAL .......................................................................................................................................................................28

46. ....................................................................................................................................................................................................................
Europe ..................................................................................................................................................................................................................................... 28
47. ....................................................................................................................................................................................................................
Africa....................................................................................................................................................................................................................................... 29

III. INTERNATIONAL..................................................................................................................................................................................................29
48. ....................................................................................................................................................................................................................
WHO, Geneva .......................................................................................................................................................................................................................... 30

5
Working document QAS/11.453
page 6
I. NATIONAL

COUNTRY TITLE 1. PHARMACOPOEIA COMMISSIONS DEITION YEA LANGUAGE

2. PUBLISHER/DISTRIBUTOR R
3. ONLINE ACCESS ADDRESS
4. FREQUENCY OF PUBLICATION

Argentina Farmacopea Argentina 1. & 2. Farmacopea Argentina 8th Edition* (vol.1,2,3,4) 2011 Spanish
Administración Nacional de Medicamentos, 7th Edition, vol.1 2002
th
Alimentos y Tecnología Médica (ANMAT) 6 Edition 1978
th
Avenida de Mayo 869 (C1084AAD) - Ciudad 5 Edition 1966
Autónoma de Buenos Aires - Argentina 4th Edition 1956
Website: http://www.anmat.gov.ar (Spanish) 3rd Edition 1943
nd
E-mail: fa@anmat.gov.ar 2 Edition 1921
st
1 Edition 1893

* the content that is on

public consultation since
2011

3. Farmacopea Argentina
th
7 Edition (Volume1)
http://www.anmat.gov.ar/fna/septima_edicion.htm
(Spanish)
(only one volume approved and published (vol.
1). The online access address of 7th edition are just
the index of the approved vol. 1 and the content
intended to be included in the vol. 2 and vol. 3 that
were not published.)
th
8 Edition (Volume 1,2,3,4)
http://www.anmat.gov.ar/webanmat/fna/octava_edicion
.asp (Spanish)

(the content is on public consultation since 2011)


Austria Österreichisches Arzneibuch
(ÖAB)
(Austrian Pharmacopoeia)
Working document QAS/11.453
page 7
1. Österreichische Arzneibuchkommission Official Edition 2011 German
Bundesministerium für Gesundheit
Radetzkystr.2, A - 1031 Wien
Website: http://www.bmg.gv.at (English, German)
E-mail: pamela.rendi-wagner @bmg.gv.at

2. Verlag Österreich GmbH,

Bäckerstr. 1, A – 1010 Wien
Website:http://www.verlagoesterreich.at/cdrom---
22406.html

4. yearly

Belarus Государственной 1. The Pharmacopoeial-and-Pharmaceutical Analysis 1st Edition, vol.1 2006 Russian
фармакопеи Республики Laboratory of the Centre for Expertise and Testing in vol.2 2008
Беларусь Health Care,The Ministry of Health of the Republic of vol.3 2009
(State Pharmacopoeia of Belarus
the Republic of Belarus) 2a Tovarishesky Lane, Minsk, 220037, Republic of
Belarus
Website: http://www.rceth.by/lffaeng.htm (Russian, English)
E-mail: info@rceth.by

2. Ministry of Health of the Republic of Belarus

220048, Minsk, Miasnikov street, 39

Belgium 1. Belgian Pharmacopoeia Commission

Federal Agency for Medicines and Health Products
EUROSTATION building, block 2
place Victor Horta, 40/ 40
1060 Brussels
Website: http://www.fagg-afmps.be(Dutch,English, French)
E-mail: moise.essoh@afmps.be

7
Working document QAS/11.453
page 8

Brazil Farmacopéia Brasileira 1&2. Agência Nacional de Vigilância Sanitária – 5th Edition ,Vol.1,2 2010 Portuguese
th
ANVISA 4 Edition
Farmacopéia Brasileira Part 1 1988
SIA, Excerpt 5, 57 Special Area Part 2 ,Vol.1 1996
Cidade: Brasília - DF Vol.2 2000
City: Brasília - DF Vol.3 2002
CEP: 71.205-050 Vol.4 2003
Website: http://www.anvisa.gov.br(Portuguese) Vol.5 2004
E-mail: farmacopeia@anvisa.gov.br Vol.6 2005
rd
3 Edition 1976
2nd Edition 1957
1st Edition 1929

3. Farmacopéia Brasileira
http://www.anvisa.gov.br/hotsite/cd_farmacopeia/index.htm
(Portuguese)

Farmacopeia 1,2. see above 3rd Edition 2011 Portuguese

nd
Homeopática Brasileira 2 Edition 1997
st
(Brazilian Homeopathic 1 Edition 1976
Pharmacopoeia)
3. Farmacopéia Homeopática Brasileira
http://www.anvisa.gov.br/farmacopeiabrasileira/conteu
do/3a_edicao.pdf(Portuguese)

China 1. Chinese Pharmacopoeia Commission

State Food and Drug Administration
Building 11 Fahua Nan li, Chongwen District, 100061
Beijing,China
Website: http://www.chp.org.cn (Chinese)
E-mail: chpc@chp.org.cn

th
Pharmacopoeia of the 2. China Medico-Pharmaceutical Science & 9 Edition 2010 Chinese, English
People's Republic of Technology Publishing House 8th Edition 2005 Chinese, English
China http://www.cmstp.com 7th Edition 2000 Chinese, English
 Working document QAS/11.453
page 9
6th Edition 1995 Chinese, English
th
A-22, Northern WenHuiYuan Road, Haidian District, 5 Edition 1990 Chinese, English
th
Beijing 100082, P. R. China 4 Edition 1985 Chinese ,English
3rd Edition 1977 Chinese
2nd Edition 1963 Chinese
st
4. once every five years 1 Edition 1953 Chinese

Croatia 1. Pharmacopoeia Commission,

Agency for Medicinal Products and Medical Devices of
Croatia
Ksaverska cesta 4
10 000 Zagreb
Website: http://www.almp.hr (Croatian, English)
E-mail: halmed@halmed.hr

Hrvatska Farmakopeja 2. Croatian Pharmaceutical Society 2007 Croatian

(Croatian (Hrvatsko Farmaceutsko Društvo)
Pharmacopoeia) Masarykova 2, 10000 Zagreb
Website: http://www.hfd-fg.hr/about_us.asp
(Croatian,English)
E-mail: hfd-fg-ap@zg.t-com.hr

3. Hrvatska Farmakopeja Croatian

http://narodne-ovine.nn.hr/clanci/sluzbeni/297531.html

Czech 1. Pharmacopoeia Commission

Republic State Institute for Drug Control
Ministry of Health of the Czech Republic
Šrobárova 48,100 41 Praha 10,Czech Republic
Website: http://www.sukl.eu (Czech,English)
E-mail: posta@sukl.cz

Český lékopis 2. Vydala Grada Publishing a.s. U Pruhonu 466/22, Edition (MMIX) 2009 Czech
Praha 7-Holešovice, Jako svou 1739. publikaci Supplement 2010
Edition (MMV) 2005

9
Working document QAS/11.453
page 10
Supplement1 2006
Supplement2 2007
Edition (MMII) 2002
Supplement1 2003
Supplement2 2004
Supplement3 2005
Edition (MCMXCVII) 1997
Supplement1 1999
Supplement2 2000
Supplement3 2001
4th Edition 1987 4th edition is the last
Supplement 1991 authentic and teamwork
3rd Edition ,Vol.1,Vol.2 1970 pharmacopoeia for the
Supplement 1976 Czech and Slovak
nd
2 Edition 1954 Republic
supplement 1959
1st Edition 1947
supplement 1953

Denmark 1. Danish Pharmacopoeia Commission

Danish Medicines Agency
Axel Heides Gade 1
DK-2300 København S
Website:http://www.dkma.dk (Danish, English)
E-mail: dkma@dkma.dk

Egypt Egyptian Pharmacopoeia 1. Permanent Commission of the Egyptian 4th Edition 2005 Arabic, English
Pharmacopoeia,The Egyptian Drug Authority 3rd Edition 1984
21 Abd El-Aziz Al Soud Street, EL-Manial, Cairo, 2nd Edition 1972
st
Egypt, 1 Edition 1953
Website: http://www.eda.mohp.gov.eg (Arabic,English)
E-mail: plan.imp@eda.mohealth.gov.eg

2. General Organization for Government Printing

Office, Cairo
 Working document QAS/11.453
page 11
Finland 1. FIMEA Pharmacopoeia Committee
Lääkealan turvallisuus- ja kehittämiskeskus
Finnish Medicines Agency (FIMEA)
P.O. Box 55, Mannerheimintie 103b, FI-00301
Helsinki
Website: http://www.fimea.fi (Finnish,Swedish,English)
E-mail : communications@fimea.fi

France 1. Commission nationale de pharmacopée

Agence Française de Sécurité Sanitaire
des Produits de Santé–Direction des Laboratoires
et des Contrôles, Unité Pharmacopée
Afssaps
143/147, bd Anatole France
93285 Saint Denis cedex
Website:http://www.afssaps.fr (French)
E-mail:pharmacopeefrancaise@afssaps.sante.fr
th
Pharmacopée française 2. Wolters Kluwer France 10 Edition 2010 French
1 rue Eugène et Armand Peugeot (Some updated texts are
92856 Rueil-Malmaison cedex in English)

4. undated yearly, Since 1998, the French

Pharmacopoeia consists of three folders regularly
updated

Germany 1. Deutsche Arzneibuch-Kommission,

Bundesinstitut für Arzneimittel und Medizinprodukte
(Federal Institute for Drugs and Medical Devices)
Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn
Website: http://www.bfarm.de (English, German)
E-mail: Arzneibuch@bfarm.de

Deutsches Arzneibuch 2. Deutscher Apotheker Verlag, Stuttgart DAB 2010 2010 German
(DAB) Medpharm GmbH Scientific Publishers, DAB1997-2009 1997-
Birkenwaldstraβe 44, D-70191 2009

11
Working document QAS/11.453
page 12
Stuttgart 10 th edition 1991
9 th edition 1986
th
4. updated yearly. 8 edition 1978
7 th edition 1964
In accordance with Section 55 of the Pharmaceuticals 1968
Act (Arzneimittelgesetz - AMG), the Pharmacopoeia 6 th editon 1926
th
and the date of entry into force of the revised version. 5 edition 1910
th
4 edition 1900
rd
3 edition 1890
nd
2 edition 1883
st
1 edition 1872

Deutsche 1. Deutsche Homöopathischen Arzneibuch HAB 2010 2010 German

Homoeopathischen Bundesinstitut für Arzneimittel und Medizinprodukte
Arzneibuch Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn
(HAB) Website:http://www.bfarm.de (English,German)
E-mail: poststelle@bfarm.de; Arzneibuch@bfarm.de

4. yearly.
2. Deutscher Apotheker Verlag, Stuttgart
Govi-Verlag- Pharmazeutischer Verlag GmbH,
Eschborn

th
Greece Greek Pharmacopoeia 1. Greek Pharmacopoeia Commission 5 Edition, vol 1,2 1998 Greek
National Organization for Medicines Supplement1 2000
Laboratory Division Supplement2 2002
Pharmacopoeia Section Supplement3 2006
Mesogeion Avenue, 284 Supplement4 2009
GR 15562 Holargos Attikis
Website:http://www.eof.gr (English, Greek)
E-mail: president@eof.gr

2. National Organisation for Medicines,

Mesogeion Street, 284
15562 Holargos Attikis
 Working document QAS/11.453
page 13
Greece

th
Hungary Magyar gyógyszerkönyv 1. Hungarian Pharmacopoeia Commission (OGYI) 8 Edition 2006 Hungarian
(Pharmacopoeia National Institute of Pharmacy 7th Edition 1987
Hungarica) 1051 Budapest, Zrínyi utca 3, 6th Edition 1967
th
Levélcím: 1372 Postafiók 450. 5 Edition 1958
th
Website:http://www.ogyi.hu/ (Hungarian,English) 4 Edition 1933
E-mail: gyogyszerkonyv@ogyi.hu 3rd Edition 1909
2nd Edition 1888
st
1 Edition 1871

2. Medicina konyvkiado, Budapest

http://www.medicina-kiado.hu

Iceland 1. The Icelandic Medicines Agency (IMA)

Lyfjastofnun
Vinlandsleid 14
113, Reykjavík
Iceland
Website: www.lyfjastofnun.is (Icelandic, English)
E-mail: ima@ima.is

13
Working document QAS/11.453
page 14
India Indian Pharmacopoeia(IP) 1&2. Office of The Secretary-cum-Scientific Director 7 th Edition 2013 English
th
Indian Pharmacopoeia Commission 6 Edition 2010
Ministry of Health and Family Welfare Addendum 2012
Government of India 5 th Edition 2007
Sector-23, Raj Nagar, Ghaziabad-201 002 Addendum 2008
th
Website: http://www.ipc.nic.in (English) 4 Edition 1996
E-mail: ipclab@vsnl.net Supplement (Vet) 2000
Addendum 2002
Addendum 2005
rd
3 Edition 1985
3. Indian Pharmacopoeia Supplement 1989
http://ipc.nic.in/usermain.asp Supplement 1991
2nd Edition 1966
Supplement 1975
st
4.By Annualy 1 Edition 1955
Supplement 1960

th
Indonesia Farmakope Indonesia 1. Indonesian Pharmacopoeia Commission 4 Edition 1995 Indonesian
Therapeutic and Household Healthcare
Standardization
National Agency of Drug and Food Control
Kesehatan R.I., Jl, Percetakan
Negara 23, Jakarta 10560
Website:http://www.pom.go.id (Indonesian, English)
E-mail: Informasi@pom.go.id

2. Departemen Kesehatan Republik Indonesia(Ministry

of Health Republic of Indonesia)
DJL. Percetakan Negara 23
Jakarta
 Working document QAS/11.453
page 15
Iran Iranian Pharmacopoeia 1. Iranian Pharmacopoeia
Drug Administration of Iran, Division of
Pharmaceuticals & Narcotic Affairs
Ministry of Health and Medical Education
P.O.Box 310,
Teheran 11344, Islamic Republic of Iran
Location: 14th floor, MOHME building, Simaye Iran
Street, Phase 5, Shahrake Qods, Teheran
Website: http://www.mohme.gov.ir(Arabic)
E-mail: Lankarani@mohme.gov.ir

Ireland 1. Irish Medicines Board

Kevin O'Malley House,
Earlsfort Centre,
Earlsfort Terrace,
Dublin 2,
Ireland
Website:http://www.imb.ie (English)
E-mail: imb@imb.ie

Italy Farmacopea Ufficiale 1. Permanent Commission of the Italian 12th Edition 2008 Italian
della Repubblica Italiana Pharmacopoeia, Istituto Superiore di Sanità 11th Edition 2002
Viale Regina Elena 299
00161 - Roma (I) Supplement(2005)
Website:http://www.iss.it (English,Italian)
E-mail:Farmcp@iss.it

2. Ministerio della Salute,Commissione

permanente per la revisione e pubblicazione
della Farmacopea Ufficiale,
Istituto Poligrafico e Zecca dello Stato P. V.,
1213045 Roma

15
Working document QAS/11.453
page 16

Japan The Japanese 1. Expert Committee on the Japanese Pharmacopoeia JP 16th 2011 Japanese, English
th
Pharmacopoeia(JP) Pharmaceuticals and Medical Devices Agency JP 15 2006 Japanese, English
Shin-kasumigaseki Building, 15 Supplement1 2007 Japanese, English
3-3-2, Kasumigaseki,Chiyoda-ku,Tokyo 100-0013 15 Supplement2 2009 Japanese, English
JAPAN JP 14th 2001 Japanese, English
Website: http://www.pmda.go.jp/english/index.html 14 Supplement1 2002 Japanese, English
(Japanese, English) 14 Supplement 2 2004 Japanese, English
E-mail: Std-jpenghp@pmda.go.jp JP 13th 1996 Japanese, English
13 Supplement1 1997 Japanese, English
13 Supplement2 1999 Japanese, English
2. Committee on the Japanese Pharmacopoeia/ JP 12th 1991 Japanese, English
Pharmaceutical Affairs Food Sanitation Council 12 Supplement1 1993 Japanese, English
Pharmaceutical and Food Safety Bureau, 12 Supplement2 1994 Japanese, English
th
Ministry of Health, Labour and Welfare JP 11 1986 Japanese, English
1-2-2, Kasumigaseki,Chiyoda-ku, Tokyo 100-8916, 11 Supplement 1988 Japanese, English
JAPAN JP 10th 1981 Japanese
Website: http://www.mhlw.go.jp/english/ (Japanese, JP 9th 1976 Japanese
th
English) JP 8 1971 Japanese
th
E-mail: IYSINSA@mhlw.go.jp JP 7 1961 Japanese
JP 6th 1951 Japanese
th
JP 5 1932 Japanese
th
JP 4 1920 Japanese
3. The Japanese Pharmacopoeia JP 3rd 1906 Japanese
http://www.pmda.go.jp/english/pharmacopoeia/index.ht JP 2nd 1891 Japanese
ml(English) JP 1st 1886 Japanese
 Working document QAS/11.453
page 17

Korea The Korean 1&2. Korea Food and Drug Administration 9th Edition 2007 Korean, English
Pharmacopoeia(KP) Osong Health Technology Administration Complex, Supplement 1 2009
187 Osongsaengmyeong2-ro, Gangoe-myeon, Supplement 2 2010
Supplement 3 2010
Cheongwon-gun, Chungcheongbuk-do, 363-951,
Supplement 4 2010
Korea Supplement 5 2010
Website:http://www.kfda.go.kr(Korean/English) Supplement 6 2011
E-mail: khs9270@korea.kr Supplement 7 2011
8th Edition 2002
Supplement 1 2006
Central Pharmaceutical Affairs Council 7th Edition 1997
5-mosaemi-gil,Yangchun-gu,Seoul,Korea Supplement 1 2000
Korea Food and Drug Administration 6th Edition 1992
Supplement 1 1993
th
5 Edition 1987
Supplement 1 1988
3. The Korean Pharmacopoeia 4th Edition 1982
http://eng.kfda.go.kr (English) Supplement 1 1982
rd
(from KFDA News to Relevant Rule) 3 Edition 1976
Supplement 1 1978
Supplement 2 1979
nd
2 Edition
Part I 1967
Part II 1968
Supplement 1 1968
Supplement 2 1969
4. Currently revised in every 5-year term 1st Edition 1958

Lithuania 1.Pharmacopoeia Commission

State Medicines Control Agency
under the Ministry of Health of the Republic of Lithuania
Rygos str. 15,
LT-05245 Vilnius
Lithuania
Website:http://www.vvkt.lt (Lithuanian,English)

17
Working document QAS/11.453
page 18
E-mail: fs.vvkt@vvkt.lt

th
Mexico Farmacopea de los 1. Comisión Permanente de la Farmacopea de 10 Edition 2011 Spanish
th
Estados los Estados Unidos Mexicanos, 9 Edition 2008
Unidos Mexicanos Rio Rhin 57,Col Supplement 2009
Cuauhtémoc, C.P. 06500, México DF 8th Edition 2004
Website:http://www.farmacopea.org.mx(Spanish) Supplement 2006
th
E-mail: cpfeum@farmacopea.org.mx 7 Edition 2000
Supplement 1 2001
Supplement 2 2002
th
2. Secretaría de Salud, 6 Edition 1994
Leija 7 Col. Juárez, C.P. 06696 Supplement 1 1995
México DF Supplement 2 1998
5th Edition 1988
Supplement 1 1990
Supplement 2 1992
4th Edition 1974
3rd Edition 1962
nd
2 Edition 1952
st
1 Edition 1931
(began new edition)
th
4 Edition 1904
rd
3 Edition 1896
2nd Edition 1884
1st Edition 1846

Mexican Herbal 1st Edition 2001 Spanish

Pharmacopoeia English
nd
Mexican Homeopathic 2 Edition 2007 Spanish
Pharmacopoeia 1st Edition 1998
 Working document QAS/11.453
page 19
1. The Republic of Montenegro, Ministry of Health
Montenegro
Rimski trg 46, PC Vektra
81000 Podgorica
Website:http://www.mzdravlja.gov.me(Croatian,English,Serbian)
E-mail: nina.milovic@gov.me
mirjana.djuranovic@gov.me

Norway 1. Norwegian Pharmacopoeia Commission

Norwegian Medicines Agency
Statens Legemiddelverk
Sven Oftedals vei 8, 0950
Post box 63, Kalbakken,
0901 Oslo
Website:http://www.slv.no (Norwegian,English)
E-mail: post@legemiddelverket.no

st
Pakistan Pakistan Pharmacopoeia 1. Pakistan Pharmacopoeia Commission, 1 Edition 1974 English
Ministry of Health
(Notes: The Ministry of Health has been devolved to
the provinces under the 18th Amendment, by the
Federal Government on June 30th 2011)

Drug Control Organization

Website: http://www.dcomoh.gov.pk (English)
E-mail: info@dcomoh.gov.pk

Government of Pakistan
Website: http://www.pakistan.gov.pk (English)

19
Working document QAS/11.453
page 20
Philippines Philippine Pharmacopeia 1. Products Services Division 1st Edition 2004 English
Bureau of Food and Drugs
Department of Health
Republic of the Philippines
San Lazaro Compound, Sta. Cruz, Manila
Website: http://www.doh.gov.ph/bfad/orgchart.html (English)
E-mail: ftduque@co.doh.gov.ph

th
Poland Farmakopea Polska 1. Pharmacopoeia Commission, 9 Edition 2012- Polish
th
Pharmacopoeia Department, 8 Edition(and 2008-
Office for Registration of Medicinal Products, supplements) 2011
Medical Devices & Biocidal Products; 7th Edition(and 2006
41 Ząbkowska Str. supplements)
th
03-736 Warsaw, Poland 6 Edition 2002
5th Edition 1990
Website: http://www.urpl.gov.pl (Polish, English) Supplement 1995
E-mail: president@urpl.gov.pl th
4 Edition
Volume 1 1965
2. Office for Registration of Medicinal Products, Volume 2 1970
Medical Devices and Biocidal Products; 3rd Edition 1954
Supplement 1 1956
41 Ząbkowska Str.
Supplement 2 1959
03-736 Warsaw, Poland Supplement 3 1962
2nd Edition 1946
st
3. Website: 1 Edition 1817
http://www.urpl.gov.pl (Polish, English)

4. yearly
 Working document QAS/11.453
page 21
Portugal Farmacopeia Portuguesa 1. INFARMED – Autoridade Nacional do Medicamento 9th Edition,Vol1,Vol2,Vol3 2008 Portuguese
e Produtos de Saúde, I.P. Supplement 9.1 2008
Comissão da Farmacopeia Portuguesa Supplement 9.2 2008
Supplement 9.3 2009
Parque de Saúde de Lisboa Supplement 9.4 2009
Avenida do Brasil, 53 Supplement 9.5 2009
1749-004 Lisboa – Portugal Supplement 9.6 2010
Website: Supplement 9.7 2010
http://www.infarmed.pt (Portuguese, English) Supplement 9.8 2010
th
8 Edition,Vol1,Vol2 2005
E-mail:infarmed@infarmed.pt
7th Edition,Vol1,Vol2 2002
6h Edition 1997
Supplement 2000

2. INFARMED – Autoridade Nacional do Medicamento

e Produtos de Saúde, I.P.
Parque de Saúde de Lisboa
Avenida do Brasil, 53
1749-004 Lisboa – Portugal
Website: http://www.infarmed.pt (Portuguese,
English)
E-mail: infarmed@infarmed.pt

4.3 years

21
Working document QAS/11.453
page 22

Republic of 1. National Control Laboratory

Serbia Medicines and Medical Devices Agency of Serbia
(ALIMS),Ministry of Health
Vojvode Stepe 458, 11152 Beograd, Srbija
Website:http://www.alims.gov.rs/(Serbian,English)
E-mail: nkl@alims.gov.rs

Pharmacopoeia Affairs Coordinator

Expert Associate in Pharmaceutical Department
E-mail:marija.maskovic@alims.gov.rs

Romania Farmacopeea Romana 1. Romanian Pharmacopoeia Commission A X-A 1993 Romanian

National Medicines Agency Supplement 2000
Aviator Sanatescu 48, R-71324 Bucuresti Supplement 2001
Website:http://www.anm.ro (Romanian,English) Supplement 2004
E-mail:Constantin.popescu@anm.ro Supplement 2006

2. Editura Medicala- Bucuresti

Russian Государственной 1. Pharmacopoeia Committee, Federal Service on 12th Edition,Vol.1 2008 Russian
Federation Фармакопеи Российской Surveillance in Healthcare and Social Development 11th Edition
Федерации (Roszdravnadzor),Ministry of Health Vol.1 1987
109074, Москва, Славянская площадь, д.4, стр.1 Vol.2 1990
(State Pharmacopoeia of Website: http://www.roszdravnadzor.ru/contacts.html 10th Edition 1968
the Russian Federation, E-mail: info@roszdravnadzor.ru 9th Edition 1961
th
former title: State 8 Edition 1946
th
Pharmacopoeia of the 7 Edition 1925
Union of Soviet Socialist 6th Edition 1910
Republics) 5th Edition 1902
th
4 Edition 1891
rd
3 Edition 1880
2nd Edition 1871
1st Edition 1778
 Working document QAS/11.453
page 23
2. Medicina, Petroverigskiy Pereulok 6/8, 101000
Moscow

st
Slovak Pharmacopoea Slovaca 1. Slovak Pharmacopoeia Commission/ 1 Edition, volume l 1997 Slovak
Republic Slovenský liekopis Slovenská liekopisna komisia volume ll 1999
State Institute for Drug Control volume lll 2000
Kvetná 11, 825 08 Bratislava 26 Slovak Republic volume IV 2001
Website:http://www.sukl.sk(Slovak ,English) volume V 2002
E-mail: sukl@sukl.sk volume VI 2002
volume VII 2004
st
Slovenský farmaceutický 2. Ministry of Health, 1 Edition 2007 Slovak
kódex Vydavatel’stvo Herba spol. s r.o. 1997
Bratislava

3. Codex Pharmaceuticus Slovacus MMVII

http://suklt.ui42.sk/buxus/docs//Posudzovanie_kvality_li
ekov/kodex2007.pdf

Slovenia 1. Pharmacopoeia Commission

Agency For Medicinal Products and Medical Devices of
the Republic of Slovenia (Javna Agencija Za Zdravila In
Medicinske Pripomočke - Jazmp
PTUJSKA ULICA 21, 1000 LJUBLJANA
Website: http://www.jazmp.si (English, Slovenian)
E-mail:info@jazmp.si

23
Working document QAS/11.453
page 24
Spain Real Farmacopea 1. Secretaría Técnica de la Real Farmacopea Española 4th Edition 2011 Spanish
rd
Española Agencia Española del Medicamentos y Productos 3 Edition 2005
nd
Sanitarios 2 Edition 2002
C/ Campezo 1, edificio 8, 2ª planta. Supplement 2.1 2002
E - 28022 Madrid Supplement 2.2 2003
st
Website: http://www.aemps.gob.es (Spanish, 1 Edition 1996
English) Supplement 1.1 1997
Supplement1.2 1978
E-mail: smhaem@aemps.es
Supplement1.3 2000
Supplement1.4 2001
2. Publicación:
Agencia Estatal Boletín Oficial del Estado
Avda. Manoteras 54
E – 28050 Madrid
Website: http://www.boe.es/
E-mail: farmacopea@boe.es

3. Real Farmacopea Española

http://extranet.boe.es/index.php?referer=/farmacope
a/index.php

Sweden 1. Swedish Pharmacopoeia Commission,

Medical Products Agency
P.O. Box 26, SE-751 03 Uppsala, SWEDEN
Website: http://www.lakemedelsverket.se (Swedish,English)
E-mail address format: firstname.surname@mpa.se
or
Contact online:
http://www.lakemedelsverket.se/english/top/Contact-us
 Working document QAS/11.453
page 25
Switzerland Pharmacopoea Helvetica 1. Commission Suisse de Pharmacopée 10th Edition 2006 French
Swissmedic Supplement 10.1 2007 German
Swiss Agency for Therapeutic Products Supplement 10.2 2009 Italian
Pharmacopoeia Division Supplement 10.3 2010
P.O Box
Hallerstrasse 7
3000 Bern 9
Website:http://www.swissmedic.ch(English, French,,
German, Italian)
E-mail:pharmacopoeia@swissmedic.ch

2. Office fédéral des constructions et de la logistique

Fellerstrasse 21, CH-3003 Bern
www.bundespublikationen.admin.ch

st
Thailand Thai Pharmacopoeia 1&2. Thai Pharmacopoeia Committee 1 Edition
Bureau of Drug and Narcotic Department of Medical Vol. I Part 1 1987 English
Sciences Vol. I Part 2 1993
Ministry of Public Health Vol. II Part 1 1997
Nonthaburi 11000, Thailand Vol. II Part 2 2000
Website: Vol. II Part 3 2003
http://www.dmsc.moph.go.th/webroot/drug/eng/res Supplement 2005
Supplement 2010
ponsiblility.stm (English, Thai)
E-mail: rojana@dmsc.moph.go.th

2. Thai Pharmacopoeia and Reference Substance

Section
Bureau of Drug and Narcotic
Department of Medical Sciences
Ministry of Public Health
Tiwanond Road, Nonthaburi 11000, Thailand

Thai Herbal 1. & 2. as above Vol.1 1995 English

Pharmacopoeia Vol.2 2000
Supplement 2004
Vol.3 2009

25
Working document QAS/11.453
page 26

Turkey 1. Commission of the Turkish Pharmacopoeia

General Directorate of Pharmaceuticals and Pharmacy
Ministry of Health
Söğütözü Mahallesi 2176. Sokak No:5 P.K.
06520 Çankaya/ANKARA
Website:http://www.iegm.gov.tr (Turkish,English)
E-mail:ebru.cora@iegm.gov.tr

Ukraine ДЕРЖАВНА 1. Ukrainian Pharmacopoeial Center 1st Edition 2001 Ukrainian

ФАРМАКОПЕЯ УКРАЇНИ The State Expert Center Supplement 1 2004
(The State Pharmacopoeia Ministry of Health of Ukraine Supplement 2 2008
of the 40, Ushinskyi St. Supplement 3 2009
Ukraine) 03151 Kyiv Supplement 4 2011
Ukraine
Website:http://www.pharma-center.kiev.ua
(Ukrainian,Russian,English)
E-mail:public@pharma-center.kiev.ua

Ukrain Scientific Center Pharmacopoeial Quality of

drugs
Astronomicheskaya st. 33
61085 Kharkov, Ukraine
Website:http://www.sphu.org
E-mail: phukr@phukr.kharkov.ua

2. Publisher:“RIREG”, Kharkov
Distributor: Pharmacopoeial Center,
Astronomicheskaya st. 33
61085 Kharkov, Ukraine
 Working document QAS/11.453
page 27

United British Pharmacopoeia 1. British Pharmacopoeia Commission BP 2012 English

Kingdom Medicines and Healthcare products Regulatory Agency BP 2010
(MHRA) BP 2009
151 Buckingham Palace Road BP 2011
Victoria,London, SW1W 9SZ
nd
Website:http://www.pharmacopoeia.gov.uk(English) 2 1914
st
E-mail:bpcom@mhra.gsi.gov.uk 1 Edition(through the 1864
merger of the London,
2. The Stationery Office, London Edinburgh and Dublin
Pharmacopoeias)
3. British Pharmacopoeia
http://www.pharmacopoeia.co.uk/login.htm

4. yearly

United States The United States 1. & 2. The United States Pharmacopeia
of America Pharmacopeia 12601 Twinbrook Parkway USP 35, NF 30 2011 English
The National Rockville, MD 20852 -1790, USA USP 34, NF 29 2010
Formulary(USP-NF) Website: http://www.usp.org(English, Spanish, Supplement 1 2011
Chinese, Portuguese) Supplement 2 2011
E-mail:execsec@usp.org
1942-
3. USP-NF 2000
http://www.uspnf.com/uspnf/login
USP 20,NF 15 1980

4. Yearly USP 2 1830

USP 1 1820
− Since 2002,USP-NF published annually
− 1980, USP XX and the NF XV published under
same cover
− 1942-2000,published every 5 year
− 1830-1942,revisions at 10-year intervals

27
Working document QAS/11.453
page 28
Pharmacopoeia 1. & 2. Vietnamese Pharmacopoeia Commission 4th Edition 2009 Vietnamese
Viet Nam Vietnamica Vietnamese Pharmacopoeia and Formulary Center 2010 English
Ministry of Health – S.R. Vietnam
rd
3 Edition 2002 Vietnamese
48- Hai Ba Trung Str, Hoan Kiem Dist.,Hanoi, Vietnam 2005 English
Website:http://www.moh.gov.vn(English, Vietnamese) supplement 2006
E-mail: hddvn@vnn.vn 2nd Edition Vietnamese
vol.1 1990
vol.2 1991
vol.3 1994
st
1 Edition
vol.1 1970
supplement 1977
vol.2 1983

II. REGIONAL AND SUBREGIONAL

European Pharmacopoeia 1. & 2. European Directorate for the Quality of 7th Edition ( 7.0) 2011 English, French
th
Europe Medicines& HealthCare, Council of Europe 7 Edition (7.1) 2011
th
7 allée Kastner, CS 30026 7 Edition (7.2) 2011
F-67081 Strasbourg,France 7th Edition (7.3) 2012
Website:http://www.edqm.eu(English, French) 7th Edition (7.4) 2012
th
E-mail: caroline.letarnec@edqm.eu 6 Edition 2008
th
5 Edition 2005
4th Edition 2002
3. European Pharmacopoeia 3rd Edition 1997
nd
http://online.edqm.eu/entry.htm 2 Edition 1980
st
1 Edition 1967

4. New Edition every three years. Supplements

three times yearly (March, June, November)

Pharmeuropa 1. & 2. as above Vol. 23.1 - 3 2011 English, French

Vol. 22.1 - 4 2010
3. Pharmeuropa
http://online6.edqm.eu/phpadownload/
 Working document QAS/11.453
page 29

4. Four times yearly

36 Member States and the European Union are signatory to the Convention on the Elaboration of a European Pharmacopoeia.

European Pharmacopoeia Members:

Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary,
Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain,
Sweden, Switzerland, "the former Yugoslav Republic of Macedonia", Turkey, United Kingdom, and the European Union.

( Last membership: Poland (2006))

Africa African Pharmacopoeia 1&2. Committee on Scientific and Technical Vol.1 1985 English
Research, African Union (AU-STRC) Vol.2 1986 English
26/28 NPA BUILDING
4th Floor
Marina ,Lagos
Nigeria
Website: http://au-strc.org/en/excdir.asp(English)
Contact: http://au-strc.org/en/contactus.asp
st
African Herbal Pharmacopoeia 1&2. Association for African Medicinal Plants 1 Edition 2010 English
(AfrHP) Standards
C/O Executive Services Ltd
2nd Les Jamalacs Building,
Vieux Conseil Street
Port Louis
Republic of Mauritius
Website: http://www.aamps.org (English/French)
E-mail: secretary@aamps.org

III. INTERNATIONAL

29
Working document QAS/11.453
page 30
1. WHO Expert Committee on Specifications
WHO, Geneva for Pharmaceutical Preparations
Website:http://www.who.int/medicines/services/e
xpertcommittees/pharmprep/en/index.html
(English)

E-mail: empinfo@who.int

The International 2. WHO Press 4th Edition, Vol. 1,2 2006 English
Pharmacopoeia World Health Organization, 1st Supplement 2008
1211 Geneva 27, Switzerland 2nd Supplement 2011
FAX (41-22) 791 48 57
rd
E-mail bookorders@who.int 3 Edition, Vol.1 1979 English
1980 French
1980 Spanish
1981 Russian
Arabic

Vol. 2 1981 English

1981 French
1983 Spanish
1983 Russian
Arabic

Vol. 3 1988 English

1988 French
1989 Spanish
1990 Russian
Arabic

Vol. 4 1994 English

1994 French
1996 Spanish
1995 Russian
Arabic

Vol. 5 2003 English

 Working document QAS/11.453
page 31
Arabic

2nd Edition
Reagents 1963 English
1966 French
quality control (QC) 1967 English
1967 French
supplement for QC 1971 English
1971 French

1st Edition 1951 English

1955 French
1959 Spanish
Germany
Japanese

3.The International Pharmacopoeia

http://apps.who.int/phint/en/p/about/

***

31